Effects of traditional Chinese medicine nursing combined with conventional nursing in patients with chronic obstructive pulmonary disease: a meta-analysis
, , , and | Mar 26, 2018
About this article
Article Category: Original article
Published Online: Mar 26, 2018
Page range: 61 - 68
Received: Jun 03, 2017
Accepted: Jun 27, 2017
DOI: https://doi.org/10.1515/fon-2018-0009
Keywords
© 2018 Shanxi Medical Periodical Press
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1
Figure 2
Figure 3
Figure 4
Results of meta-analysis of outcomes
| Outcomes | Number of studies | Number of patients | Pooled WMD | 95% CI of pooled WMD | Heterogeneity | |||
|---|---|---|---|---|---|---|---|---|
| Study group | Control group | |||||||
| SGRQ scores | 4 | 273 | 273 | –15.06 | –16.56 to 13.55 | 0.000 | 0.0 | 0.990 |
| FEV1 value | 6 | 371 | 371 | 0.29 | 0.13 to 0.45 | 0.000 | 95.7 | 0.000 |
| FEV1/FVC value | 11 | 588 | 586 | 4.95 | 2.71 to 7.19 | 0.000 | 96.2 | 0.000 |
| FEV1% value | 4 | 511 | 511 | 9.20 | 4.71 to 13.68 | 0.000 | 97.8 | 0.000 |
| FEV1 predicted value | 4 | 192 | 190 | 4.13 | 3.44 to 4.82 | 0.000 | 0.0 | 0.725 |
| Hospital stay | 4 | 259 | 259 | –3.96 | –5.79 to 1.94 | 0.000 | 95.9 | 0.000 |
Study characteristics and inclusion criteria
| Articles | Study period | Case | Number in study group | Number in control group | Outcomes 1= SGRQ scores; 2= FEV1 Value; 3= FEV1/FVC Value; 4= FEV1% value; 5= FEV1 predicted value; 6= hospital stay; 7= clinical efficacy. | Quality assessment |
|---|---|---|---|---|---|---|
| Dai 2016 | 2012/11–2015/12 | COPD | 20 | 20 | 1 | 3 |
| Li 2015 | 2013/6–2015/6 | Stable COPD | 50 | 50 | 1,3, 5 | 3 |
| He 2014 | 2010/12–2013/10 | Stable COPD | 60 | 60 | 1,3, 5 | 3 |
| Zheng et al 2014 | 2011/1–2012/12 | Stable COPD | 143 | 143 | 1,2, 3, 5 | 4 |
| Peng 2009 | 2007/1–2009/1 | Stable COPD | 50 | 50 | 2, 3 | 3 |
| Chen et al 2015 | – | Stable COPD | 53 | 53 | 2, 3, 7 | 4 |
| Li 2015 | 2014/1–2014/12 | Stable COPD | 43 | 43 | 2 | 4 |
| Zuo et al 2015 | 2013/4–2014/3 | COPD | 36 | 36 | 2, 3 | 3 |
| Pei et al 2015 | 2014/6–2015/6 | Stable COPD | 46 | 46 | 2, 3, 7 | 4 |
| Shi et al 2014 | 2013/5–2013/12 | Acute exacerbation COPD | 15 | 15 | 3, 4 | 4 |
| Liu 2014 | 2013/1–2014/1 | COPD | 53 | 53 | 3, 4 | 4 |
| Wang et al 2015 | 2013/7–2014/7 | COPD | 40 | 38 | 3, 5 | 4 |
| Huang 2016 | 2012/10–2014/10 | Stable COPD | 42 | 42 | 3, 5 | 3 |
| Li et al 2013 | 2008/1–2013/2 | Stable COPD | 300 | 300 | 4, 7 | 3 |
| Fu et al 2014 | 2012/1–2013/12 | Acute exacerbation COPD | 50 | 50 | 6 | 4 |
| Lei 20 1 4 | 2012/8–2014/2 | COPD | 100 | 100 | 6, 7 | 4 |
| Liang et al 2010 | 2008/1–2009/1 | Acute exacerbation COPD | 45 | 45 | 6 | 4 |
| Pan 2013 | 2011/4–2012/3 | Acute exacerbation COPD | 64 | 64 | 6, 7 | 4 |
| Fan 201 5 | 2013/5–2015/5 | COPD | 40 | 40 | 7 | 3 |
| Zhang et al 2013 | 2011/1–2013/1 | Acute exacerbation COPD | 27 | 27 | 7 | 4 |
| Nie et al 2012 | 2011/1–2011/11 | Acute exacerbation COPD | 120 | 120 | 7 | 3 |
| Han 201 5 | 2013/9–2014/10 | Acute exacerbation COPD | 60 | 60 | 7 | 4 |